Microvascular Complications of Diabetes

Nursing Clinics of North America

Volumn 41, Issue 4, 2006, Pages 719-736

  Cypress, Marjorie ^a   Tomky, Donna ^b  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b Lovelace Sandia Health Systems   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; HUMAN; MICROCIRCULATION; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SKIN DISEASE;

DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; HUMANS; MICROCIRCULATION; RISK FACTORS; SKIN DISEASES;

EID: 33750068590     PISSN: 00296465     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnur.2006.07.009     Document Type: Review

References (55)

1. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent-diabetes mellitus. N Engl J Med 329 (1993) 977-986
2. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK prospective diabetes study (UKPDS) group. Lancet 352 (1998) 837-853
3. Koro C.E., Bowlin S.J., Bourgeois N., et al. Glycemic control from 1988 to 2000 among US adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care 27 (2004) 17-20
4. Centers for Disease Control. National diabetes fact sheet, United States 2005. Available at: www.cdc.gov/diabetes/pubs/factsheet05. Accessed February 16, 2006.
5. Ryan M.E., Carnu O., and Kramer A. The influence of diabetes on periodontal tissue. J Am Dent Assoc 134 (2003) 34S-40S
6. Home P. Contributions of basal and post-prandial hyperglycemia to micro- and macrovascular complications in people with type 2 diabetes. Curr Med Res Opin 21 (2005) 989-998
7. Dandona P., Chaudhuri A., and Aljada A. Endothelial dysfunction and hypertension in diabetes mellitus. Med Clin North Am 88 (2004) 911-931
8. CDC. Risk factors for complications: national diabetes surveillance system. Available at: www.cdc.gov/diabetes/statistics/comp/us.htm. Accessed January 23, 2006.
9. Harris M.I., Klein R., Cowie C.C., et al. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A US population study. Diabetes Care 21 (1998) 1230-1235
10. Harris M.I., Eastman R.C., Cowie C.C., et al. Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care 22 (1999) 403-408
11. Harris M.I. Racial and ethnic differences in health care access and health outcomes for adults with type 2 diabetes. Diabetes Care 24 (2001) 454-459
12. American Diabetes Association. Standards of medical care in diabetes: 2006 position statement. Diabetes Care 29 (2006) S4-S42
13. Institute of Medicine. Unequal treatment: confronting racial and ethnic disparities in health care 2002 (2002), National Academy of Sciences, Washington
14. Writing team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287 (2002) 2563-2569
15. The UKPDS Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: the UKPDS report no. 38. BMJ 317 (1998) 703-713
16. Jenkins A.J., Rowley K.G., Lyons T.J., et al. Lipoproteins and diabetic microvascular complications. Curr Pharm Des 10 (2004) 3395-3418
17. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
18. Sheetz M.J., and King G.L. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 288 (2002) 2579-2588
19. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54 (2005) 1615-1625
20. Feldman EL. Etiology of diabetic microvascular disease and scientific rationale for new therapeutic targets. Advanced Studies in Medicine 2005;5:S138-43.
21. Fong D.S., Aiello L.P., Ferris F.L., et al. Diabetic retinopathy (technical review). Diabetes Care 27 (2004) 2540-2553
22. van Leiden H.A., Dekker J.M., Moll A.C., et al. Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol 121 (2003) 245-251
23. Frank R.N. Medical progress: diabetic retinopathy. N Engl J Med 350 (2004) 48-58
24. American Academy of Ophthalmology. Preferred practice patterns: diabetic retinopathy. Available at: www.aao.org/education/library/ppp/upload/Diabetic-Retinopathy.pdf. Accessed February 12, 2006.
25. Phelps R. Ocular changes with diabetes. In: Childs B., Cypress M., and Spollett G. (Eds). Complete nurse's guide to diabetes care (2005), American Diabetes Association, Alexandria (VA) 113-121
26. Wilson C., Horton M., Cavallerano J., et al. Addition of primary care-based retinal imaging technology to an existing eye care professional referral program increased the rate of surveillance and treatment of diabetic retinopathy. Diabetes Care 28 (2005) 318-322
27. Hutchinson A., McIntosh A., Peters J., et al. Effectiveness of screening and monitoring tests for diabetic retinopathy: a systematic review. Diabet Med 17 (2000) 495-506
28. Klein B.E., Klein R., McBride P.E., et al. Cardiovascular disease, mortality and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiology study of diabetic retinopathy. Arch Intern Med 164 (2004) 1917-1924
29. Gross J.L., de Azevcdo M.J., Silverberg S.P., et al. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28 (2005) 164-176
30. Rabkin R. Diabetic nephropathy. Clin Cornerstone 5 (2003) 1-11
31. Molitch M., DeFronzo R., Franz M., et al. Nephropathy in diabetes. Diabetes Care 27 (2004) S79-S83
32. National Kidney Foundation. K/DOQI Clinical practice guidelines. Available at: www.kidney.org/professional/kdoqi/guidelines_ckd/toc.htm. Accessed December 1, 2005.
33. Levey A.S., Eckardt K., Tsukamoto Y., et al. Definition and classification of chronic kidney disease: a position statement from kidney disease. Improving global outcomes. Kidney Int 67 (2005) 2089-2100
34. Coonrod B., and Ernst K.L. Nephropathy. In: Franz M. (Ed). A core curriculum for diabetes educators: diabetes and its complications. 5th edition (2003), AADE, Chicago 153-188
35. Viassara H., and Palace M.R. Diabetes and advanced glycation endproducts. J Intern Med 251 (2002) 87-101
36. Coughlan M.T., Cooper M.E., and Forbes J.M. Can advanced glycation end product inhibitors modulate more than one pathway to enhance renoprotection in diabetes. Ann N Y Acad Sci 1043 (2005) 750-758
37. Levin A., and Stevens L.A. Executing change in the management of chronic kidney disease: perspectives on guidelines and practice. Med Clin North Am 89 (2005) 701-709
38. Nathan D. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290 (2003) 2159-2167
39. Waugh N.R., and Robertson A.M. Protein restriction for diabetic renal disease. Cochrane Database Syst Rev 2 (2002) CD02181
40. Ngo B.T., Hayes K.D., DiMiao D.J., et al. Manifestations of cutaneous diabetic microangiopathy. Am J Clin Dermatol 6 (2005) 225-237
41. Iacopino A.M. Diabetic periodontitis: possible lipid-induced defect in tissue repair through alterations of macrophage phenotype and function. Oral Dis 1 (1995) 214-229
42. Borrell L.N., and Papapanou P.N. Analytical epidemiology of periodontitis. J Clin Periodontol 32 (2005) 132-158
43. Saremi A., Nelson R.G., Tullock-Reid M., et al. Periodontal disease and mortality in type 2 diabetes. Diabetes Care 28 (2005) 27-32
44. Stegeman C.A. Oral manifestations of diabetes. Home Healthc Nurse 23 (2005) 233-242
45. Shemer A., Bergman R., Linn S., et al. Diabetic dermopathy and internal complications in diabetes mellitus. Int J Dermatol 37 (1998) 113-115
46. Spollett G. Dermatological changes associated with diabetes. In: Childs B.P., Cypress M., and Spollett G. (Eds). Complete nurse's guide to diabetes care (2005), ADA, Alexandria (VA) 146-154
47. He Z., and King G.L. Can protein kinase C B-selective inhibitor, ruboxistaurin, stop vascular complications in diabetic patients?. Diabetes Care 28 (2005) 2803-2805
48. Tuttle K.R., Bakris G.L., Toto R.D., et al. The effect of ruboxistaurin on nephropathy in type 2 diabetes. Diabetes Care 28 (2005) 2686-2690
49. Mulcahy K., Maryniuk M., Peeples M., et al. Technical review: diabetes self management education outcome measures. Diab Educ 29 (2003) 768
50. Walker R. Diabetic retinopathy: protecting the vision of people with diabetes. Br J Community Nurs 9 (2004) 545-547
51. Seaman S. The role of the nurse specialist in the care of patients with diabetic foot ulcers. Foot Ankle Int 26 (2005) 19-26
52. Stern E., Benbassat C.A., and Goldfracht M. Impact of a two-arm educational program for improving diabetes care in primary care centres. Int J Clin Pract 59 (2005) 1126-1130
53. Hensley R.D., Jones A.K., Williams A.G., et al. One-year clinical outcomes for Louisiana residents diagnosed with type 2 diabetes and hypertension. J Am Acad Nurse Pract 17 (2005) 363-369
54. Wilson C., Curtis J., Lipke S., et al. Nurse case manager effectiveness and case load in a large clinical practice: implications for workforce development. Diabet Med 22 (2005) 1116-1120
55. Adiseshiah M. Effective care of patients with type 2 diabetes and dyslipidemia: a nurse's perspective. Diabetes Res Clin Pract 68 (2005) S23-S27